Skip to main content
. 2018 Oct 31;8:16113. doi: 10.1038/s41598-018-34305-x

Figure 1.

Figure 1

Characterization of ATMs in Ipra-treated WT mice fed a HFD. Six-week-old WT mice were fed a HFD for 16 weeks and were administered the vehicle (DMSO) or Ipra during the last 4 weeks. (a) The ontology terms enriched among the upregulated (>1.5-fold) mRNAs in Epi from HFD-fed mice treated with Ipra compared with those from HFD-fed mice treated with vehicle. The results are expressed as −log (p value). (b) Representative plots and quantification of flow cytometry for M1-like (CD11c+CD206 cells) and M2-like (CD11cCD206+ cells) adipose tissue macrophages (ATMs, CD45+CD11b+F4/80+ cells) in Epi, and M1-like/M2-like ratio (n = 4, each group). (c) Gene expression levels of CD206 (Mrc1) and CD301b (Mgl2) in the sorted ATMs (n = 4). (d) Representative plots and quantification of flow cytometry for Ly6C high (Ly6Chi) and low (Ly6Cl°) monocytes, and neutrophils (Neut) in the peripheral blood (n = 4). (e) Slc5a2 mRNA levels in sorted ATMs, Epi, isolated adipocytes (Adipo), stromal vascular fraction (SVF), and kidney of HFD-fed mice (n = 4). All values are presented as mean ± SEM. *p < 0.05 vs. vehicle.